SCHEMBL13993479

SCHEMBL13993479

C/N=C(/NC)NC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13299287 1.00
SCHEMBL27859503 0.85 SIGMAR1 (0.35)
SCHEMBL13993532 0.75 CA12 (0.40)
SCHEMBL22894093 0.75 KDM1A (0.38)
SCHEMBL5525764 0.75 KDM1A (0.38)
SCHEMBL244973 0.75
SCHEMBL23510728 0.74 NOS1 (0.32)
SCHEMBL23134387 0.72 TSHR (0.39)
SCHEMBL3225990 0.72 CA12 (0.30)
SCHEMBL18756522 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10711036-B2 MALT1 inhibitors and uses thereof CORNELL UNIVERSITY (US) 2020-07-14 US disclosed
US-20080318957-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2008-12-25 US disclosed